Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The association of XRCC3 Thr241Met genetic variant with risk of prostate cancer: a meta-analysis.

African health sciences - 1 Mar 2015

Xuan Gao, Hui Ying, Fang He

Abstract excerpt

BACKGROUND: Previous studies suggest that the X-ray repair cross-complementing group 3 gene (XRCC3) Thr241Met genetic variant could be potentially associated with the risk of prostate cancer. However, results from these published studies were conflicting rather than conclusive. OBJECTIVES: his meta-analysis aimed to conduct a better understanding of the effects of XRCC3 Thr241Met genetic variant on prostate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to DNA-Binding Proteins
Share to XRCC3 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Variation

Share to Polymorphism, Genetic

Share to Prostatic Neoplasms

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 25834539
DOI: 10.4314/ahs.v15i1.16
PMCID: PMC4370129

Genes

XRCC3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The association of XRCC3 Thr241Met genetic variant with risk of prostate cancer: a meta-analysis.PMID 25834539Read ↗

Association between the Thr241Met polymorphism of X-ray repair cross-complementing group 3 gene and glioma risk: evidence from a meta-analysis based on 4,136 cases and 5,233 controls.Semantic proximity Read ↗

Genetic polymorphisms of XRCC3 Thr241Met (C18067T, rs861539) and bladder cancer risk: a meta-analysis of 18 research studies.Semantic proximity Read ↗

Association between X-ray repair cross-complementing group 1 Arg194Trp polymorphism and prostate cancer risk.Semantic proximity Read ↗

Association between the XRCC3 Thr241Met polymorphism and risk of colorectal cancer: a meta analysis of 5,193 cases and 6,645 controls.Semantic proximity Read ↗

Association between the XRCC3 Thr241Met polymorphism and breast cancer risk: an updated meta-analysis of 36 case-control studies.Semantic proximity Read ↗

X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism significantly associated with prostate cancer.Semantic proximity Read ↗

Association between XRCC3 Thr241Met Polymorphism and Risk of Breast Cancer: Meta-Analysis of 23 Case-Control Studies.Semantic proximity Read ↗

Arg399Gln substitution in XRCC1 as a prognostic and predictive biomarker for prostate cancer: Evidence from 8662 subjects and a structural analysis.Semantic proximity Read ↗

XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

Association between the XRCC3 T241M polymorphism and risk of cancer: evidence from 157 case-control studies.Semantic proximity Read ↗

Meta-Analysis of the Relationship between XRCC1-Arg399Gln and Arg280His Polymorphisms and the Risk of Prostate Cancer.Semantic proximity Read ↗

XRCC3 Thr241Met polymorphism and ovarian cancer risk: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.